iifl-logo

Molbio Diagnostics Ltd Share Price Live

Add as a Preferred Source on Google
1,086.3
(-0.77%)
Aug 31, 2026|09:28:59 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open1,102.1
  • Day's High1,161.1
  • 52 Wk High1,264.6
  • Prev. Close1,094.75
  • Day's Low1,065.2
  • 52 Wk Low 926.35
  • Turnover (lac)12,585.07
  • P/E86.89
  • Face Value1
  • Book Value0
  • EPS12.63
  • Mkt. Cap (Cr.)12,518.52
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Molbio Diagnostics Ltd KEY RATIOS

Sector

Healthcare

Open

₹1,102.1

Prev. Close

₹1,094.75

Turnover(Lac.)

₹12,585.07

Day's High

₹1,161.1

Day's Low

₹1,065.2

52 Week's High

₹1,264.6

52 Week's Low

₹926.35

Book Value

₹0

Face Value

₹1

Mkt Cap (₹ Cr.)

12,518.52

P/E

86.89

EPS

12.63

Divi. Yield

0

Molbio Diagnostics Ltd Corporate Action

27 Aug 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Molbio Diagnostics Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Molbio Diagnostics Ltd SHAREHOLDING SNAPSHOT

31 Aug, 2026|05:02 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 46.64%

Foreign: 0.00%

Indian: 46.64%

Non-Promoter- 53.35%

Institutions: 53.35%

Non-Institutions: 0.00%

Custodian: 0.00%

Share PriceShare Price

Molbio Diagnostics Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

2.26

2.6

2.6

2.25

Preference Capital

0

0

0

0

Reserves

987.82

847.38

736.37

681.04

Net Worth

990.08

849.98

738.97

683.29

Minority Interest

View Balance Sheet

No Record Found

No Record Found

No Record Found

Particulars (Rupees in Crores.)Mar-2026Mar-2025Mar-2024Mar-2023

Gross Sales

1,445.69

1,020.42

836.56

332.46

Excise Duty

0

0

0

0

Net Sales

1,445.69

1,020.42

836.56

332.46

Other Operating Income

0

0

0

0

Other Income

9.48

7.52

4.1

4.95

Molbio Diagnostics Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

8,838.5

80.511,27,187.59385.20.232,656.1692.92

Manipal Health Enterprises Ltd

MANIPALHOS

771.65

227.681,01,527.39115.5301,048.3100.51

Max Healthcare Institute Ltd

MAXHEALTH

1,014.1

134.8998,597.77167.60.2782.9291.84

Fortis Healthcare Ltd

FORTIS

926.75

352.2770,211.1147.780.11489.45122.24

Aster DM Quality Care Ltd

ASTERDM

748.4

209.964,952.67-14.30.24725.7353.52

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Molbio Diagnostics Ltd

Management

Register Office

Registrar Office

Executive Director & CEO

SRIRAM NATARAJAN

Executive Director / Chief Technology Officer

CHANDRASEKHAR NAIR

Executive Director (Operation)

SANGEETHA SRIRAM

Independent Non Exe. Director

Arun Kumar Jha

Independent Non Exe. Director

Dr Balram Bhargava

Independent Non Exe. Director

Nupur Garg

Company Sec. & Compli. Officer

Darshan Raghunath Karekar

Registered Office

No.L-46 Phase II-D,

Verna Industrial Area Verna,

Goa - 403722

Tel: +91 832 6724 888

Website: http://www.molbiodiagnostics.com

Email: investors@molbiodiagnostics.com

Registrar Office

Karvy Selenium Tow-B,

31&32 Financial Dist, Nanakramguda,

Hyderabad-500032

Tel: 91-40-67162222

Website: www.kfintech.com

Email: einward.ris@karvy.com

Summary

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited at Panaji, as a private company dated October 20, 2000. Thereafter, Company was converted from a private li...
Read More

Company FAQs

The Molbio Diagnostics Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1086.3 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Molbio Diagnostics Ltd is ₹12518.52 Cr. as of 31 Aug ‘26
The PE and PB ratios of Molbio Diagnostics Ltd is 86.89 and 10.63 as of 31 Aug ‘26
The 52-week high/low is the highest and lowest price at which a Molbio Diagnostics Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Molbio Diagnostics Ltd is ₹926.35 and ₹1264.6 as of 31 Aug ‘26
Molbio Diagnostics Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at N/I%, 6 Month at N/I%, 3 Month at N/I% and 1 Month at 5.09%.
The shareholding pattern of Molbio Diagnostics Ltd is as follows:
Promoters - 41.29 %
Institutions - 17.89 %
Public - 40.82 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.